Most Popular

The Top 15 BioPharmaceutical Manufacturers by 2018 Revenue

Journey of Generic Imatinib - A Case Study in Oncology Drug Pricing

Should drug prices differ by indication?

Who funded the COVID-19 vaccines?

How much does it costs to develop a new drug -- start to finish?

HTA’d in the USA: A Comparison of ICER in the United States with NICE in England and Wales.

The End of the International Reference Pricing System?

UK provides first full access deal in Europe for new CAR-T therapy.

Detailed drug pricing information across 36 countries.

The following are some of the largest U.S. legal settlements involving the pharmaceutical industry.

Who pays for your medication?

Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study.

Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020

Developing new medicines and the evolving nature of commercialization.

Outcome-Based Payment (OBP) schemes are commercial arrangements where a medicine’s price is linked to the outcomes achieved for patients receiving the medicine in real-world clinical practice.